Improved Pharma Scientists to Present Groundbreaking Research at International Workshop
Improved Pharma, a leading research and consulting firm in the pharmaceutical industry, is set to showcase groundbreaking research at the upcoming Spring Pharmaceutical Synchrotron-XRPD (SPS-XRPD) Workshop in Basel, Switzerland. The event, scheduled for May 6-8, will bring together experts from the pharmaceutical and synchrotron communities to exchange ideas and explore innovative techniques in pharmaceutical development.
The presentation, titled 'Detecting Crystalline Domains in Amorphous Materials: A Comparative Study', will be delivered by Dr. Pam Smith and Ruba Alajlouni, both of whom are experts in their field. The research focuses on the critical aspect of detecting crystalline domains in amorphous materials, which is essential for ensuring the shelf-life stability of pharmaceuticals. By utilizing alternative techniques such as Raman spectroscopy and hot-stage polarized microscopy, the team aims to provide valuable insights into the behavior of amorphous dispersions.
'We are thrilled to be participating in the SPS-XRPD workshop once again,' says Dr. Smith, COO of Improved Pharma. 'This event provides a unique platform for us to share our research with like-minded professionals and learn from their expertise. Continued scientific research in this field is crucial for advancing the development of pharmaceutical drugs and ensuring their safety and efficacy.'
The presentation will compare the results obtained using Raman spectroscopy and hot-stage polarized microscopy with those obtained using synchrotron XRPD coupled with PDF analysis. This comparative study will offer valuable insights into the effectiveness of different techniques in detecting crystalline domains in amorphous materials. The findings will be of great interest to researchers and professionals in the pharmaceutical industry, as they can help improve the stability and efficacy of drug formulations.
Improved Pharma is a research, consulting, and information company dedicated to improving pharmaceutical methods, formulations, and processes. The company offers a range of services, including solid-state form studies, formulation design, synchrotron techniques, analytical testing, and expert consulting. Founded in 2006 by Stephen and Sarah Byrn, Improved Pharma has established itself as a trusted partner for pharmaceutical companies seeking to develop and defend their intellectual property.
For more information about Improved Pharma's services and the upcoming SPS-XRPD workshop, please visit their website or contact their team directly. The company's commitment to scientific research and innovation makes it an invaluable resource for the pharmaceutical industry, and its participation in the SPS-XRPD workshop is a testament to its dedication to advancing the field.
In my opinion, the presentation by Improved Pharma at the SPS-XRPD workshop is a significant development in the field of pharmaceutical research. The comparative study of different techniques for detecting crystalline domains in amorphous materials has the potential to revolutionize the way we approach drug development and formulation. As a researcher in the pharmaceutical industry, I am excited to see the impact of this work and look forward to the future advancements it will enable.
